Literature DB >> 22512239

Evaluation of the correlation between self-report and electronic monitoring of adherence to hypertension therapy.

Adedokun Ayoade1, Idris Oladipo.   

Abstract

Blood pressure (BP) control remains sub-optimal all over the world. Medication adherence is an important determinant of BP control. None of the available methods for measuring medication adherence is currently regarded as a universal consensus gold standard. In this study, we evaluated the correlation between self-report (Morisky's Medication Adherence Self-assessment Scale) and electronic (eCap) methods of medication adherence assessment. The self-report measure was administered at study entry while electronic compliance data was collected prospectively. Almost all (97.4%) of enrolled patients completed the study. Medication adherence scores ranged from 0 to 100% (69.33, ± 27.57) and 6.6-100% (66.92 ± 22.59) for Morisky's scale and eCap, respectively (Wilcoxon rank sum test, p = 0.253). Modal class interval for adherence scores were 61-80% (n = 28, 37.3%) and 81-100% (n = 23, 30.7%) for the eCap and Morisky's scale respectively. Overall, a weak correlation was found between the two methods (r = 0.056). The weak correlation was also maintained in subgroup analysis defined by attainment of BP control (r = 0.109 vs 0.0009), age (range r = -0.53 to 0.067), sex (0.009 to 0.151), level of education (-0.217 to 0.276), and Mini Mental State Examination score (-0.107 to 0.258). Our findings suggest that these methods are not equivalent in the evaluation of medication adherence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22512239     DOI: 10.3109/08037051.2012.679029

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  5 in total

Review 1.  Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices: An Updated Review.

Authors:  Alisha Monnette; Yichen Zhang; Hui Shao; Lizheng Shi
Journal:  Pharmacoeconomics       Date:  2018-01       Impact factor: 4.981

2.  Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial.

Authors:  Rosa L de Jager; Erik M van Maarseveen; Michiel L Bots; Peter J Blankestijn
Journal:  Br J Clin Pharmacol       Date:  2017-10-10       Impact factor: 4.335

Review 3.  Monitoring treatment adherence in hypertension.

Authors:  Serap Erdine; Eren Arslan
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

4.  Prevalence and associated factors of self-reported hypertension among Tehran adults in 2011: a population-based study (Urban HEART-2).

Authors:  Bahman Cheraghian; Mohsen Asadi-Lari; Mohammad Ali Mansournia; Reza Majdzadeh; Kazem Mohammad; Saharnaz Nedjat; Mohammad Reza Vaez-Mahdavi; Soghrat Faghihzadeh
Journal:  Med J Islam Repub Iran       Date:  2014-09-29

5.  Patients' and healthcare providers' perceptions and practices regarding hypertension, pharmacy-based care, and mHealth in Lagos, Nigeria: a mixed methods study.

Authors:  Anne L Cremers; Abiola Alege; Heleen E Nelissen; Tochi J Okwor; Akin Osibogun; René Gerrets; Anja H Van't Hoog
Journal:  J Hypertens       Date:  2019-02       Impact factor: 4.844

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.